Driving Performance After Middle of the Night Administration of 3.5 mg Zolpidem Tartrate Sublingual Tablet
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
A study in healthy volunteers of the next morning driving performance after
middle-of-the-night dosing of 3.5 mg zolpidem tartrate sublingual tablet, a sleep aid. The
next morning driving performance will be measured by taking a standardized driving test.